InvestorsHub Logo
Followers 0
Posts 36
Boards Moderated 0
Alias Born 03/09/2017

Re: MadCityCyclone post# 19053

Wednesday, 11/07/2018 10:21:21 AM

Wednesday, November 07, 2018 10:21:21 AM

Post# of 20689
They may have to litigate to protect their patents on their novel drug platform, but as a follower of Momenta for the last 3 years, it seemed the larger pharma companies like Teva found ways to delay entry by drawn out expensive litigation. My point was Momenta is more of a pure play biotech story. Lots of risk but substantial upside if any of their novel drugs get approved.